12-04-2018 | E-learning | gesteund door: Bristol-Myers Squibb
What are immune biomarkers?
- PDL-1
- Micro Satellite Instability
- Tumor Mutational Burden
- Final exam
After completing this e-learning you will have a broader knowledge of:
- The definition and potential role of biomarkers in oncology
- The basics and clinical relevance of immune-biomarkers in particular PD-L1, TMB and MSI
- The potential benefit and challenges of each of these biomarkers in the near future
Accreditation has been granted for 1 point by:
- NVO until 6 May 2019;
- NVALT until 12 May 2020;
- NVVP until 24 April 2020;
- NIV until 12 May 2020;
- NVRO until 6 May 2020.
Educational grant by BMS